"Carcinoma, Ehrlich Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.
Descriptor ID |
D002286
|
MeSH Number(s) |
C04.557.470.200.200 C04.619.169
|
Concept/Terms |
Carcinoma, Ehrlich Tumor- Carcinoma, Ehrlich Tumor
- Ehrlich Tumor Carcinoma
- Ehrlich Ascites Tumor
- Ascites Tumor, Ehrlich
- Tumor, Ehrlich Ascites
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Ehrlich Tumor".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Ehrlich Tumor".
This graph shows the total number of publications written about "Carcinoma, Ehrlich Tumor" by people in this website by year, and whether "Carcinoma, Ehrlich Tumor" was a major or minor topic of these publications.
Below are the most recent publications written about "Carcinoma, Ehrlich Tumor" by people in Profiles.
-
Genistin modulates high-mobility group box protein 1 (HMGB1) and nuclear factor kappa-B (NF-κB) in Ehrlich-ascites-carcinoma-bearing mice. Environ Sci Pollut Res Int. 2023 Jan; 30(1):966-978.
-
Dietary baker's yeast sensitizes Ehrlich mammary adenocarcinoma to paclitaxel in mice bearing tumor. Oncol Rep. 2019 Jun; 41(6):3155-3166.
-
99mTc-phytate as a diagnostic probe for assessing inflammatory reaction in malignant tumors. Nucl Med Commun. 2015 Oct; 36(10):1042-8.
-
Translocator protein (18 kDa) mediates the pro-growth effects of diazepam on Ehrlich tumor cells in vivo. Eur J Pharmacol. 2010 Jan 25; 626(2-3):131-8.
-
Saccharomyces cerevisiae, the Baker's Yeast, suppresses the growth of Ehrlich carcinoma-bearing mice. Cancer Immunol Immunother. 2008 Apr; 57(4):581-92.
-
Chloroquine treatment increases detection of 5-fluorouracil-induced apoptosis index in vivo. Mol Imaging. 2006 Jul; 5(3):148-52.
-
Structure-activity profiles of complex biantennary glycans with core fucosylation and with/without additional alpha 2,3/alpha 2,6 sialylation: synthesis of neoglycoproteins and their properties in lectin assays, cell binding, and organ uptake. J Med Chem. 2002 Jan 17; 45(2):478-91.
-
Antitumor activities of vanadium(IV), manganese(IV), iron(III), cobalt(II) and copper(II) complexes of 2-methylaminopyridine. Cancer Lett. 1998 Nov 13; 133(1):71-6.
-
Lack of correlation between antitumour response and serum interferon levels in mice treated with SSM, an immunotherapeutic anticancer agent. Br J Cancer. 1986 Apr; 53(4):567-70.
-
Ability of sera from mice treated with Ge-132, an organic germanium compound, to inhibit experimental murine ascites tumours. Br J Cancer. 1985 Nov; 52(5):757-63.